71 reports

  • GENE THERAPY TO REVERSE THE PROGRESSION OF PD
  • MARKET OVERVIEW

According to some studies, PD is a neurological disorder caused by genetic mutations.

  • Psychotic Disorder
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • 2.1 Psychosis: An Overview

Genetic factors include a variety of common and rare genetic variants.

  • Psychotic Disorder
  • World
  • Market Size
  • Johnson & Johnson
  • Lundbeck Inc.
  • SCHIZOPHRENIA

The major cause of schizophrenia is either genetic in origin or exposure to environmental factors such as exposure to cannabis, poor nutrition during pregnancy, and certain infections.

  • Psychotic Disorder
  • Forecast
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

Schizophrenia

4546 5000 3864
  • A DEEPER KNOWLEDGE OF SCHIZOPHRENIA'S CAUSES COULD HELP FURTHER DRUG DEVELOPMENT
  • Disease Definition and Diagnosis

Carroll LS, Owen MJ (2009) Genetic overlap between autism, schizophrenia and bipolar disorder.

  • Psychotic Disorder
  • Europe
  • Japan
  • Alkermes plc
  • AstraZeneca PLC
  • SCHIZOPHRENIA

The major cause of schizophrenia is either genetic in origin or exposure to environmental factors such as exposure to cannabis, poor nutrition during pregnancy, and certain infections.

  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • 2.1 DISEASE BACKGROUND

Biological Insights from ## Schizophrenia-Associated Genetic Loci.

  • Psychotic Disorder
  • France
  • Japan
  • United Kingdom
  • Forecast

ADHD ALSO HAS A STRONG GENETIC COMPONENT.

  • Psychotic Disorder
  • China
  • Trade
  • AstraZeneca China Inc.
  • Beijing Sihuan Pharmaceutical Co., Ltd.

Parkinson's disease

4546 5000 3864
  • GENETIC FORMS OF PARKINSON'S DISEASE ARE UNCOMMON
  • ENVIRONMENTAL FACTORS COMBINED WITH A GENETIC PREDISPOSITION MAY CAUSE PARKINSON'S DISEASE
  • Psychotic Disorder
  • Europe
  • Acorda Therapeutics, Inc.
  • Boehringer Ingelheim GmbH
  • Impax Laboratories, Inc.
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.2 RISK FACTORS AND COMORBIDITIES

IMAGING ], blood and genetic testing.

  • Psychotic Disorder
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

ADHD ALSO HAS A STRONG GENETIC COMPONENT.

  • Psychotic Disorder
  • China
  • Demand
  • Market Size
  • Trade
  • 2.1 Disease Introduction
  • Secondary symptoms

Advances in genetic research have led to the identification of genetic factors that play a causative role in familial PD and are associated with its onset.

  • Psychotic Disorder
  • World
  • Forecast
  • Novartis AG
  • Parkinson Study Group
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.1 DISEASE BACKGROUND

MANY STUDIES HAVE CONCLUDED THAT THE GENETIC COMPONENT IS AN IMPORTANT RISK FACTOR FOR PARKINSON' S DISEASE.

  • Psychotic Disorder
  • Forecast
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • DIAGNOSIS OF THE DISEASE
  • REFERENCES

Genetic factors associated with dementia in Parkinson' s disease (PD).

  • Mental Health
  • Psychotic Disorder
  • Asia
  • Europe
  • North America

Genetic Disorders and Undisclosed.

  • Psychotic Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

The major causes of urine incontinence among women include multiple childbirth, menopause, overweight, genetic weakness, damaged nerves in the bladder, weak bladder muscles, blockage of urethra, tumors, and mental confusion associated with dementia or arthritis.

  • Psychotic Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • EnteroMedics Inc.

Genetic Factors Linked to Parkinson’s Disease PARK## (parkin/ ubiquitin E## ligase) PINK## (PTEN-induced kinase ## protein) GBA (glucocerebrosidase) Promising Biomarkers for Parkinson’s Disease SNCA (?

  • Dementia
  • Mental Health
  • Pathology
  • Psychotic Disorder

AN ATTRACTIVE ALTERNATIVE TO THE USE OF GENETICALLY ENGINEERED FIBROBLASTS IS IMMORTALIZED NSCS, WHICH ARE CREATED VIA GENETIC MANIPULATION.

  • Psychotic Disorder
  • United States
  • Athersys, Inc.
  • ISCC
  • Vericel Corporation
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

In the second half of this year, Aevi Genomics plans to initiate a Phase ## trial of AEVI-## in a smaller genetic subset to confirm genetic responders.

  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • Addex Therapeutics Ltd
  • Genetic Test - Schizophrenia Genetic Test - Schizophrenia Product Overview
  • Genetic Test - Schizophrenia - Product Status
  • Biomarker
  • Psychotic Disorder
  • United States
  • World
  • GlobalData's company
  • PAIN

CARDIOVASCULAR DISEASES Nov 2014 Medgenics, Children' s Hospital of Philadelphia Discovery ## ## Collaboration agreement for pediatric rare and orphan genetic diseases No Jun 2017 Eiger BioPharmaceuticals, Theragene Pharmaceuticals ##. ## ##. ## Asset purchase agreement for Mydicar (rAAV##-SER

  • Gene Therapy
  • Psychotic Disorder
  • Therapy
  • United States
  • uniQure N.V.
  • PARKINSON'S DISEASE
  • MULTIPLE SCLEROSIS

GENETIC LINK TO PSORIASIS AND PSORIATIC ARTHRITIS ##. ## GRANT AWARD FOR $##, ## FOR MOLECULAR MEDICINE LABORATORY TESTING SERVICES FOR NPM## LABORATORY TESTING SERVICES FOR NPM## ##. ## LICENSING AGREEMENT FOR NPM## TECHNOLOGY ##. ## LICENSING AGREEMENT FOR INTELLECTUAL PROPERTY RELATED TO RHPPCA N

  • Diagnostics
  • Healthcare
  • Psychotic Disorder
  • United States
  • Company Operations
  • 4.4.1 Alzheimer's Disease
  • 7.1.2 Pipeline Programs Targeting Glucosylceramidase

Genetic Rat Models of Parkinson' s Disease.

  • Dementia
  • Psychotic Disorder
  • World
  • Deals & Alliance
  • Biogen Idec Inc.
  • SMALL MOLECULE TO INHIBIT LRRK-2 FOR PARKINSON'S DISEASE - DRUG PROFILE
  • GNE-7915 - DRUG PROFILE

Mutations in the LRRK## gene are the most frequent genetic cause of Parkinson s disease and a major driver of lysosomal dysfunction, which contributes to the formation of lewy body protein aggregates and neurodegeneration.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Oncodesign SA

The company offers raw genetic data and ancestry-related genetic reports.

  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • United States
  • Lundbeck Inc.

Report covers products from therapy areas Central Nervous System, Cardiovascular and Genetic Disorders which include indications Psychiatric Disorders, Bipolar Disorder (Manic Depression), Major Depressive Disorder, Schizophrenia, Attention Deficit Hyperactivity Disorder (ADHD), Autism, Anx

  • Psychotic Disorder
  • Therapy
  • United States
  • World
  • Product Initiative
  • Psychotic Disorder
  • Stem Cell
  • United States
  • Company Financials
  • ISCC
  • PF-06447475 - DRUG PROFILE
  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Oncodesign SA
  • TAK-058 - DRUG PROFILE
  • TAK-058 - DRUG PROFILE

This includes data from multiple genetically modified rodent models where reduction in NR##B expression impairs cognitive performance and increases in NR##B expression improve cognitive performance.

  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • ANAVEX-273 - DRUG PROFILE

Characterized as an autism spectrum disorder, Angelman syndrome is a rare neuro-genetic disorder that occurs in one in ##, ## live births.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Product Development Milestones

In study HBBM, pomaglumetad methionil did not separate from placebo in the primary efficacy endpoint in either the overall or predefined genetic subpopulation at the two doses investigated.

  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • Addex Therapeutics Ltd